Pharmacogenetic Test Should Be Added To 6-MP Label, FDA Cmte. Says
Executive Summary
GlaxoSmithKline's Purinethol (mercaptopurine) should include labeling recommending use of pharmacogenetic testing to guide dosing, the Clinical Pharmacology Subcommittee of FDA's Pharmaceutical Science Advisory Committee concluded at its Oct. 23 meeting
You may also be interested in...
Roche Launches Test Assessing Drug Metabolism; First Target Is Psychiatrists
Roche Diagnostics is targeting psychiatrists via a medical education program as part of the launch of its AmpliChip CYP450 genomic test that assesses how patients metabolize certain drugs
Roche Launches Test Assessing Drug Metabolism; First Target Is Psychiatrists
Roche Diagnostics is targeting psychiatrists via a medical education program as part of the launch of its AmpliChip CYP450 genomic test that assesses how patients metabolize certain drugs
Pediatric Formulations Of Oral Oncologics Sought By FDA
FDA is trying to encourage developers of oral cancer agents to create pediatric formulations as part of the development process